Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Progal-BT

Progal-BT
2003 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$550K LATEST DEAL AMOUNT
Description

Developer of alimentary additives for strengthening immune systems. The company specializes in developing alimentary additives from a fungus named Ganoderma lucidum using biotechnological processes for strengthening the immune system

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • Calle 25
  • Number 65 D 53
  • Medellín
  • Colombia

+57 000000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Progal-BT’s full profile, request a free trial.

Progal-BT Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 01-Apr-2013 $550K 00000 00.000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Progal-BT Executive Team (2)

Name Title Board
Seat
Contact
Info
Sergio Urrego Ph.D Executive Director
Victoria E. Santamaria E. Socia Fundadora